| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder Neoplasms | 14 | 2025 | 507 | 4.240 |
Why?
|
| Metabolomics | 24 | 2025 | 455 | 3.300 |
Why?
|
| Metabolome | 20 | 2024 | 316 | 1.710 |
Why?
|
| Mitochondria | 12 | 2025 | 730 | 1.640 |
Why?
|
| Biomarkers, Tumor | 15 | 2025 | 1559 | 1.570 |
Why?
|
| Cell Line, Tumor | 37 | 2025 | 3497 | 1.220 |
Why?
|
| Gene Expression Regulation, Neoplastic | 22 | 2024 | 1931 | 1.160 |
Why?
|
| Fatty Acids | 10 | 2025 | 351 | 1.130 |
Why?
|
| Glutamine | 6 | 2024 | 196 | 1.090 |
Why?
|
| Fatty Acids, Volatile | 3 | 2020 | 41 | 0.970 |
Why?
|
| Oxidative Phosphorylation | 4 | 2025 | 126 | 0.960 |
Why?
|
| Glioma | 5 | 2025 | 479 | 0.950 |
Why?
|
| Mice | 68 | 2026 | 17594 | 0.950 |
Why?
|
| Prostatic Neoplasms | 10 | 2022 | 1396 | 0.890 |
Why?
|
| Glutaminase | 1 | 2024 | 17 | 0.870 |
Why?
|
| Breast Neoplasms | 13 | 2024 | 2581 | 0.870 |
Why?
|
| Animals | 80 | 2026 | 33045 | 0.850 |
Why?
|
| Pancreatic Neoplasms | 5 | 2024 | 713 | 0.820 |
Why?
|
| Feces | 5 | 2024 | 702 | 0.780 |
Why?
|
| Gastrointestinal Microbiome | 9 | 2024 | 796 | 0.750 |
Why?
|
| Cigarette Smoking | 2 | 2023 | 62 | 0.740 |
Why?
|
| Triple Negative Breast Neoplasms | 5 | 2025 | 267 | 0.740 |
Why?
|
| Androgens | 4 | 2023 | 268 | 0.730 |
Why?
|
| Proto-Oncogene Proteins c-myc | 6 | 2024 | 193 | 0.720 |
Why?
|
| Glucose | 11 | 2025 | 839 | 0.710 |
Why?
|
| Urinary Bladder | 3 | 2026 | 247 | 0.690 |
Why?
|
| Brain Neoplasms | 5 | 2025 | 1224 | 0.680 |
Why?
|
| Isocitrate Dehydrogenase | 6 | 2025 | 66 | 0.660 |
Why?
|
| Inactivation, Metabolic | 1 | 2019 | 26 | 0.630 |
Why?
|
| Aldehyde Oxidase | 1 | 2019 | 7 | 0.620 |
Why?
|
| Humans | 108 | 2025 | 126679 | 0.620 |
Why?
|
| Neurotransmitter Agents | 1 | 2020 | 140 | 0.620 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2019 | 66 | 0.610 |
Why?
|
| DNA Methylation | 6 | 2020 | 1025 | 0.610 |
Why?
|
| Glycolysis | 9 | 2022 | 167 | 0.600 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2019 | 28 | 0.600 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 5 | 2023 | 90 | 0.600 |
Why?
|
| CpG Islands | 1 | 2019 | 329 | 0.580 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 4 | 2025 | 67 | 0.560 |
Why?
|
| Pentose Phosphate Pathway | 6 | 2021 | 44 | 0.550 |
Why?
|
| Cell Proliferation | 14 | 2025 | 2397 | 0.550 |
Why?
|
| Receptors, Androgen | 7 | 2023 | 402 | 0.540 |
Why?
|
| Xenograft Model Antitumor Assays | 14 | 2025 | 946 | 0.540 |
Why?
|
| Signal Transduction | 14 | 2025 | 4472 | 0.530 |
Why?
|
| Liver | 11 | 2023 | 1763 | 0.480 |
Why?
|
| Mice, Inbred C57BL | 18 | 2026 | 4502 | 0.470 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2024 | 774 | 0.470 |
Why?
|
| Metabolic Flux Analysis | 2 | 2019 | 12 | 0.460 |
Why?
|
| Chromatography, Liquid | 6 | 2019 | 230 | 0.460 |
Why?
|
| Lipid Metabolism | 5 | 2022 | 353 | 0.460 |
Why?
|
| Amino Acids | 3 | 2023 | 615 | 0.450 |
Why?
|
| Female | 50 | 2025 | 68275 | 0.440 |
Why?
|
| Energy Metabolism | 7 | 2025 | 761 | 0.440 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 4 | 2023 | 393 | 0.440 |
Why?
|
| Carbon Isotopes | 2 | 2018 | 229 | 0.440 |
Why?
|
| Nuclear Receptor Coactivator 2 | 4 | 2018 | 144 | 0.430 |
Why?
|
| Ribonucleoside Diphosphate Reductase | 1 | 2014 | 12 | 0.430 |
Why?
|
| Mass Spectrometry | 7 | 2019 | 348 | 0.420 |
Why?
|
| Isotope Labeling | 1 | 2013 | 93 | 0.410 |
Why?
|
| Carbon | 3 | 2025 | 88 | 0.410 |
Why?
|
| Phosphates | 1 | 2013 | 108 | 0.400 |
Why?
|
| Male | 43 | 2025 | 62490 | 0.400 |
Why?
|
| Fecal Microbiota Transplantation | 4 | 2024 | 104 | 0.400 |
Why?
|
| RNA, Long Noncoding | 3 | 2021 | 228 | 0.390 |
Why?
|
| Neuroblastoma | 3 | 2022 | 539 | 0.370 |
Why?
|
| Insulin Resistance | 5 | 2022 | 665 | 0.370 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2024 | 165 | 0.360 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 2 | 2022 | 22 | 0.360 |
Why?
|
| Oxidative Stress | 4 | 2026 | 756 | 0.360 |
Why?
|
| Cytokines | 7 | 2023 | 1317 | 0.350 |
Why?
|
| Disease Models, Animal | 19 | 2024 | 4426 | 0.350 |
Why?
|
| Epigenesis, Genetic | 4 | 2020 | 708 | 0.350 |
Why?
|
| Head and Neck Neoplasms | 3 | 2023 | 586 | 0.350 |
Why?
|
| Circulating Tumor DNA | 2 | 2022 | 35 | 0.350 |
Why?
|
| Dronabinol | 2 | 2021 | 30 | 0.340 |
Why?
|
| Cell Differentiation | 4 | 2025 | 1842 | 0.340 |
Why?
|
| src-Family Kinases | 2 | 2025 | 90 | 0.340 |
Why?
|
| Aging | 3 | 2026 | 1191 | 0.330 |
Why?
|
| Mice, Nude | 9 | 2025 | 708 | 0.330 |
Why?
|
| Epithelial-Mesenchymal Transition | 4 | 2025 | 235 | 0.330 |
Why?
|
| Phospholipids | 3 | 2020 | 99 | 0.330 |
Why?
|
| Endometriosis | 2 | 2024 | 168 | 0.330 |
Why?
|
| Circadian Clocks | 3 | 2022 | 82 | 0.320 |
Why?
|
| Tumor Microenvironment | 8 | 2023 | 628 | 0.320 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 2 | 2022 | 51 | 0.320 |
Why?
|
| X-Box Binding Protein 1 | 2 | 2020 | 24 | 0.310 |
Why?
|
| Cellular Reprogramming | 3 | 2020 | 105 | 0.310 |
Why?
|
| Antineoplastic Agents | 4 | 2025 | 1758 | 0.310 |
Why?
|
| Lung Neoplasms | 6 | 2022 | 1493 | 0.300 |
Why?
|
| Oncogenes | 3 | 2020 | 162 | 0.300 |
Why?
|
| Lung | 6 | 2023 | 1516 | 0.300 |
Why?
|
| Colitis | 2 | 2021 | 156 | 0.300 |
Why?
|
| Mice, Knockout | 13 | 2023 | 3709 | 0.300 |
Why?
|
| Tissue Array Analysis | 3 | 2019 | 135 | 0.300 |
Why?
|
| Lipids | 4 | 2023 | 550 | 0.290 |
Why?
|
| Disease Progression | 7 | 2025 | 2109 | 0.290 |
Why?
|
| Premature Birth | 2 | 2025 | 402 | 0.280 |
Why?
|
| Inflammation | 4 | 2022 | 1420 | 0.280 |
Why?
|
| Placenta | 2 | 2025 | 511 | 0.280 |
Why?
|
| Case-Control Studies | 6 | 2024 | 3311 | 0.280 |
Why?
|
| Apoptosis | 7 | 2020 | 1811 | 0.270 |
Why?
|
| Transcriptome | 7 | 2022 | 1051 | 0.270 |
Why?
|
| Neoplasm Invasiveness | 5 | 2025 | 634 | 0.270 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2018 | 77 | 0.270 |
Why?
|
| Ovarian Neoplasms | 2 | 2022 | 443 | 0.270 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2020 | 606 | 0.260 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2020 | 191 | 0.260 |
Why?
|
| Receptors, Estrogen | 4 | 2019 | 714 | 0.260 |
Why?
|
| Metabolic Networks and Pathways | 4 | 2025 | 191 | 0.250 |
Why?
|
| Hyperoxia | 2 | 2022 | 134 | 0.250 |
Why?
|
| Neoplasm Proteins | 3 | 2020 | 652 | 0.250 |
Why?
|
| Survival Analysis | 3 | 2019 | 1495 | 0.250 |
Why?
|
| Neurons | 4 | 2021 | 1919 | 0.250 |
Why?
|
| Dysbiosis | 2 | 2024 | 138 | 0.250 |
Why?
|
| Phosphofructokinase-2 | 2 | 2018 | 22 | 0.240 |
Why?
|
| Prognosis | 8 | 2020 | 4772 | 0.240 |
Why?
|
| Gene Knockdown Techniques | 4 | 2021 | 372 | 0.240 |
Why?
|
| Circadian Rhythm | 2 | 2022 | 306 | 0.240 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2019 | 321 | 0.240 |
Why?
|
| Antigens, Protozoan | 2 | 2017 | 80 | 0.240 |
Why?
|
| Phosphoglycerate Mutase | 1 | 2025 | 1 | 0.240 |
Why?
|
| Plasmodium falciparum | 2 | 2017 | 92 | 0.240 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2025 | 219 | 0.240 |
Why?
|
| Gene Expression Regulation | 8 | 2021 | 2304 | 0.240 |
Why?
|
| Urothelium | 1 | 2026 | 59 | 0.230 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2025 | 35 | 0.230 |
Why?
|
| Homeostasis | 5 | 2020 | 689 | 0.230 |
Why?
|
| NF-kappa B | 3 | 2024 | 438 | 0.230 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 361 | 0.230 |
Why?
|
| Biguanides | 1 | 2025 | 10 | 0.230 |
Why?
|
| Carcinoma, Transitional Cell | 2 | 2017 | 179 | 0.230 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 374 | 0.230 |
Why?
|
| DNA-Binding Proteins | 2 | 2025 | 1877 | 0.230 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2023 | 101 | 0.230 |
Why?
|
| Promoter Regions, Genetic | 3 | 2021 | 1204 | 0.230 |
Why?
|
| Middle Aged | 9 | 2024 | 27672 | 0.220 |
Why?
|
| Carbohydrate Metabolism | 2 | 2017 | 51 | 0.220 |
Why?
|
| N-Myc Proto-Oncogene Protein | 2 | 2022 | 56 | 0.220 |
Why?
|
| Intrinsically Disordered Proteins | 1 | 2025 | 63 | 0.220 |
Why?
|
| Electron Transport Complex I | 1 | 2024 | 32 | 0.220 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2019 | 276 | 0.220 |
Why?
|
| Serine | 1 | 2025 | 160 | 0.220 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 2024 | 15 | 0.220 |
Why?
|
| Protective Agents | 2 | 2021 | 36 | 0.220 |
Why?
|
| Ribonucleotides | 1 | 2024 | 31 | 0.220 |
Why?
|
| Oncolytic Viruses | 1 | 2025 | 75 | 0.220 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2024 | 45 | 0.220 |
Why?
|
| Reactive Oxygen Species | 4 | 2025 | 493 | 0.210 |
Why?
|
| Autophagy | 2 | 2018 | 404 | 0.210 |
Why?
|
| Transcription Factor AP-1 | 1 | 2024 | 107 | 0.210 |
Why?
|
| RNA Stability | 1 | 2024 | 76 | 0.210 |
Why?
|
| Cannabinoid Receptor Agonists | 2 | 2021 | 7 | 0.210 |
Why?
|
| Oncolytic Virotherapy | 1 | 2025 | 89 | 0.210 |
Why?
|
| Neoplasm Staging | 3 | 2019 | 1283 | 0.210 |
Why?
|
| Glucuronosyltransferase | 2 | 2022 | 63 | 0.210 |
Why?
|
| beta Catenin | 1 | 2025 | 205 | 0.210 |
Why?
|
| Melanoma | 2 | 2023 | 898 | 0.210 |
Why?
|
| Kidney | 3 | 2020 | 1283 | 0.200 |
Why?
|
| Nucleotides | 2 | 2023 | 89 | 0.200 |
Why?
|
| Carcinogenesis | 3 | 2021 | 344 | 0.200 |
Why?
|
| Muscle Proteins | 2 | 2019 | 398 | 0.200 |
Why?
|
| S-Adenosylmethionine | 2 | 2019 | 27 | 0.200 |
Why?
|
| Mutation | 9 | 2025 | 5939 | 0.200 |
Why?
|
| Tryptophan | 2 | 2022 | 94 | 0.200 |
Why?
|
| Organoids | 1 | 2026 | 280 | 0.200 |
Why?
|
| Soot | 1 | 2022 | 14 | 0.190 |
Why?
|
| Extracellular Vesicles | 1 | 2023 | 54 | 0.190 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2025 | 270 | 0.190 |
Why?
|
| Tumor Cells, Cultured | 6 | 2020 | 985 | 0.190 |
Why?
|
| Glutathione Peroxidase | 1 | 2022 | 47 | 0.190 |
Why?
|
| Prostate | 2 | 2017 | 406 | 0.190 |
Why?
|
| Obesity | 4 | 2023 | 2333 | 0.190 |
Why?
|
| Glutarates | 3 | 2022 | 39 | 0.180 |
Why?
|
| Transcription Factors | 2 | 2025 | 2337 | 0.180 |
Why?
|
| DNA Adducts | 2 | 2019 | 71 | 0.180 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2022 | 63 | 0.180 |
Why?
|
| Hepatocytes | 2 | 2021 | 231 | 0.180 |
Why?
|
| Pyruvic Acid | 2 | 2018 | 37 | 0.180 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2021 | 24 | 0.180 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2021 | 9 | 0.180 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2021 | 2 | 0.180 |
Why?
|
| Chromatin Assembly Factor-1 | 1 | 2021 | 9 | 0.180 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2021 | 3 | 0.180 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2021 | 17 | 0.180 |
Why?
|
| Butyrates | 1 | 2021 | 41 | 0.180 |
Why?
|
| Smoking | 2 | 2017 | 901 | 0.180 |
Why?
|
| Phenylketonurias | 1 | 2021 | 15 | 0.180 |
Why?
|
| Cannabidiol | 1 | 2021 | 19 | 0.180 |
Why?
|
| Pneumonia | 2 | 2022 | 334 | 0.170 |
Why?
|
| Bile Acids and Salts | 2 | 2023 | 243 | 0.170 |
Why?
|
| Neoplasms, Second Primary | 1 | 2023 | 138 | 0.170 |
Why?
|
| Phenylalanine | 1 | 2021 | 120 | 0.170 |
Why?
|
| Gangliosides | 1 | 2021 | 67 | 0.170 |
Why?
|
| Neoplasm Grading | 2 | 2019 | 258 | 0.170 |
Why?
|
| Phosphorylation | 6 | 2024 | 1536 | 0.170 |
Why?
|
| Enterocytes | 1 | 2021 | 65 | 0.170 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2021 | 64 | 0.170 |
Why?
|
| Membrane Fluidity | 1 | 2020 | 16 | 0.170 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2019 | 130 | 0.170 |
Why?
|
| Monocarboxylic Acid Transporters | 2 | 2018 | 35 | 0.170 |
Why?
|
| Cisplatin | 2 | 2023 | 269 | 0.170 |
Why?
|
| Prospective Studies | 3 | 2022 | 6203 | 0.170 |
Why?
|
| Peroxisomes | 2 | 2019 | 41 | 0.170 |
Why?
|
| Aconitate Hydratase | 1 | 2020 | 11 | 0.170 |
Why?
|
| Bacteria | 2 | 2021 | 502 | 0.170 |
Why?
|
| Sirtuin 3 | 1 | 2020 | 31 | 0.170 |
Why?
|
| Alcohol Oxidoreductases | 2 | 2017 | 18 | 0.170 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 129 | 0.170 |
Why?
|
| Adipocytes, Brown | 1 | 2020 | 28 | 0.170 |
Why?
|
| Bacterial Infections | 1 | 2023 | 309 | 0.160 |
Why?
|
| Oxidation-Reduction | 5 | 2023 | 422 | 0.160 |
Why?
|
| Nuclear Receptor Coactivator 3 | 2 | 2020 | 253 | 0.160 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 196 | 0.160 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2021 | 70 | 0.160 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2020 | 49 | 0.160 |
Why?
|
| Antimalarials | 2 | 2017 | 44 | 0.160 |
Why?
|
| Blood Glucose | 2 | 2021 | 1082 | 0.160 |
Why?
|
| STAT1 Transcription Factor | 1 | 2020 | 70 | 0.160 |
Why?
|
| Deoxyglucose | 1 | 2020 | 42 | 0.160 |
Why?
|
| Glioblastoma | 1 | 2024 | 331 | 0.160 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2020 | 33 | 0.160 |
Why?
|
| Betacoronavirus | 2 | 2020 | 283 | 0.160 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2021 | 133 | 0.160 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 132 | 0.160 |
Why?
|
| Liver Cirrhosis | 2 | 2017 | 875 | 0.160 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 399 | 0.160 |
Why?
|
| Kidney Tubules | 1 | 2020 | 77 | 0.160 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 53 | 0.160 |
Why?
|
| Glucuronic Acid | 1 | 2019 | 14 | 0.160 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2019 | 16 | 0.160 |
Why?
|
| Copper-transporting ATPases | 1 | 2020 | 23 | 0.160 |
Why?
|
| Chromatography, Affinity | 1 | 2019 | 55 | 0.160 |
Why?
|
| Phosphatidylethanolamine N-Methyltransferase | 1 | 2019 | 10 | 0.160 |
Why?
|
| Muscle, Skeletal | 2 | 2019 | 971 | 0.160 |
Why?
|
| Drug Delivery Systems | 2 | 2018 | 204 | 0.160 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2020 | 85 | 0.160 |
Why?
|
| Organelles | 1 | 2019 | 21 | 0.160 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2020 | 33 | 0.160 |
Why?
|
| DNA Damage | 2 | 2026 | 498 | 0.160 |
Why?
|
| Uridine Diphosphate Glucose Dehydrogenase | 1 | 2019 | 5 | 0.160 |
Why?
|
| Aged | 7 | 2020 | 20321 | 0.150 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 74 | 0.150 |
Why?
|
| Neoplasms | 3 | 2019 | 2852 | 0.150 |
Why?
|
| NADP | 1 | 2019 | 52 | 0.150 |
Why?
|
| Kynurenine | 1 | 2019 | 26 | 0.150 |
Why?
|
| Microbiota | 2 | 2022 | 426 | 0.150 |
Why?
|
| Bacteremia | 1 | 2023 | 420 | 0.150 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 208 | 0.150 |
Why?
|
| Environmental Pollution | 1 | 2019 | 16 | 0.150 |
Why?
|
| Nuclear Proteins | 1 | 2025 | 1204 | 0.150 |
Why?
|
| Resistance Training | 1 | 2019 | 26 | 0.150 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2019 | 42 | 0.150 |
Why?
|
| Antigen Presentation | 1 | 2019 | 115 | 0.150 |
Why?
|
| Neoplastic Stem Cells | 1 | 2021 | 331 | 0.150 |
Why?
|
| Sepsis | 1 | 2023 | 493 | 0.150 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 156 | 0.150 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2022 | 211 | 0.150 |
Why?
|
| Tumor Escape | 1 | 2019 | 62 | 0.150 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 169 | 0.150 |
Why?
|
| Autism Spectrum Disorder | 1 | 2024 | 423 | 0.150 |
Why?
|
| Databases, Nucleic Acid | 1 | 2019 | 72 | 0.150 |
Why?
|
| Aldose-Ketose Isomerases | 1 | 2018 | 10 | 0.150 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2019 | 56 | 0.150 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 316 | 0.140 |
Why?
|
| Mitochondrial Proteins | 2 | 2017 | 272 | 0.140 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2020 | 148 | 0.140 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 380 | 0.140 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2018 | 3 | 0.140 |
Why?
|
| Dimethyl Fumarate | 1 | 2018 | 8 | 0.140 |
Why?
|
| Hyaluronic Acid | 1 | 2019 | 101 | 0.140 |
Why?
|
| Astrocytes | 2 | 2018 | 260 | 0.140 |
Why?
|
| Alternative Splicing | 2 | 2021 | 296 | 0.140 |
Why?
|
| Organ Specificity | 3 | 2018 | 396 | 0.140 |
Why?
|
| Postmenopause | 1 | 2019 | 141 | 0.140 |
Why?
|
| Hematopoiesis | 1 | 2020 | 207 | 0.140 |
Why?
|
| Macrophages | 2 | 2022 | 639 | 0.140 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 359 | 0.140 |
Why?
|
| Chloroquine | 1 | 2017 | 30 | 0.140 |
Why?
|
| Cell Dedifferentiation | 1 | 2017 | 20 | 0.140 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 140 | 0.140 |
Why?
|
| Apolipoproteins D | 1 | 2017 | 4 | 0.140 |
Why?
|
| Naphthalimides | 1 | 2017 | 7 | 0.140 |
Why?
|
| Protein Binding | 4 | 2025 | 1661 | 0.140 |
Why?
|
| Diabetic Nephropathies | 1 | 2019 | 113 | 0.140 |
Why?
|
| Denervation | 1 | 2017 | 26 | 0.140 |
Why?
|
| PPAR alpha | 3 | 2024 | 53 | 0.140 |
Why?
|
| Response Elements | 1 | 2018 | 99 | 0.140 |
Why?
|
| Chagas Cardiomyopathy | 1 | 2018 | 51 | 0.140 |
Why?
|
| Host-Parasite Interactions | 1 | 2018 | 71 | 0.140 |
Why?
|
| Homeodomain Proteins | 2 | 2021 | 538 | 0.140 |
Why?
|
| Cell Nucleus | 2 | 2017 | 551 | 0.140 |
Why?
|
| Endoribonucleases | 1 | 2018 | 84 | 0.130 |
Why?
|
| Adipose Tissue | 1 | 2020 | 475 | 0.130 |
Why?
|
| Apolipoprotein E4 | 1 | 2017 | 47 | 0.130 |
Why?
|
| Mutagens | 1 | 2017 | 48 | 0.130 |
Why?
|
| Colon | 1 | 2020 | 353 | 0.130 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 459 | 0.130 |
Why?
|
| Liver Neoplasms | 2 | 2019 | 1351 | 0.130 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 252 | 0.130 |
Why?
|
| Peroxisomal Disorders | 1 | 2017 | 18 | 0.130 |
Why?
|
| Survival Rate | 2 | 2019 | 2100 | 0.130 |
Why?
|
| Lipid Droplets | 1 | 2017 | 50 | 0.130 |
Why?
|
| Carcinogens | 1 | 2017 | 128 | 0.130 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 2016 | 13 | 0.130 |
Why?
|
| Huntingtin Protein | 1 | 2017 | 60 | 0.130 |
Why?
|
| Autoimmunity | 1 | 2018 | 172 | 0.130 |
Why?
|
| Tobacco Products | 1 | 2017 | 60 | 0.130 |
Why?
|
| Myocardium | 1 | 2022 | 847 | 0.130 |
Why?
|
| MicroRNAs | 2 | 2020 | 872 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2019 | 394 | 0.130 |
Why?
|
| Blotting, Western | 3 | 2015 | 1014 | 0.130 |
Why?
|
| Cyclooxygenase 2 | 1 | 2017 | 126 | 0.130 |
Why?
|
| Hematologic Neoplasms | 1 | 2020 | 294 | 0.130 |
Why?
|
| Benzimidazoles | 1 | 2017 | 147 | 0.130 |
Why?
|
| Cytochrome P-450 CYP1A1 | 2 | 2020 | 82 | 0.130 |
Why?
|
| Metalloendopeptidases | 1 | 2016 | 99 | 0.130 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 285 | 0.130 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 412 | 0.120 |
Why?
|
| Hexosamines | 1 | 2016 | 18 | 0.120 |
Why?
|
| Trans-Activators | 2 | 2021 | 675 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 1222 | 0.120 |
Why?
|
| Immune Tolerance | 1 | 2017 | 148 | 0.120 |
Why?
|
| Adult | 8 | 2025 | 30379 | 0.120 |
Why?
|
| Bone Neoplasms | 1 | 2020 | 428 | 0.120 |
Why?
|
| Huntington Disease | 1 | 2017 | 140 | 0.120 |
Why?
|
| Pandemics | 2 | 2020 | 1134 | 0.120 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 233 | 0.120 |
Why?
|
| Kidney Diseases | 1 | 2020 | 481 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 199 | 0.120 |
Why?
|
| Wilms Tumor | 1 | 2017 | 116 | 0.120 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 191 | 0.120 |
Why?
|
| Neuroglia | 1 | 2017 | 208 | 0.120 |
Why?
|
| Endometrium | 1 | 2018 | 264 | 0.120 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2021 | 552 | 0.120 |
Why?
|
| GA-Binding Protein Transcription Factor | 1 | 2015 | 5 | 0.120 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2017 | 162 | 0.110 |
Why?
|
| Cognition | 1 | 2020 | 784 | 0.110 |
Why?
|
| Intestinal Mucosa | 1 | 2020 | 754 | 0.110 |
Why?
|
| Trypanosoma cruzi | 1 | 2018 | 251 | 0.110 |
Why?
|
| Data Compression | 1 | 2014 | 11 | 0.110 |
Why?
|
| Hypertension | 1 | 2023 | 1301 | 0.110 |
Why?
|
| Mice, Transgenic | 4 | 2020 | 2310 | 0.110 |
Why?
|
| Triglycerides | 1 | 2017 | 596 | 0.110 |
Why?
|
| Rats | 4 | 2023 | 3387 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 415 | 0.110 |
Why?
|
| Young Adult | 3 | 2020 | 9655 | 0.110 |
Why?
|
| Hyperargininemia | 1 | 2014 | 13 | 0.110 |
Why?
|
| Drosophila Proteins | 2 | 2017 | 757 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 477 | 0.110 |
Why?
|
| Retinal Neurons | 1 | 2014 | 13 | 0.110 |
Why?
|
| Polyamines | 1 | 2014 | 35 | 0.100 |
Why?
|
| Arginase | 1 | 2014 | 35 | 0.100 |
Why?
|
| Orchiectomy | 1 | 2013 | 53 | 0.100 |
Why?
|
| Immunosuppressive Agents | 1 | 2018 | 649 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1302 | 0.100 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2013 | 58 | 0.100 |
Why?
|
| Histones | 3 | 2023 | 502 | 0.100 |
Why?
|
| Retinopathy of Prematurity | 1 | 2014 | 49 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 2225 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2021 | 824 | 0.100 |
Why?
|
| Exercise | 1 | 2019 | 839 | 0.100 |
Why?
|
| Animals, Newborn | 3 | 2024 | 1015 | 0.100 |
Why?
|
| Cell Survival | 3 | 2021 | 841 | 0.100 |
Why?
|
| Retinal Degeneration | 1 | 2014 | 96 | 0.100 |
Why?
|
| In Vitro Techniques | 1 | 2014 | 822 | 0.100 |
Why?
|
| Cell Line | 4 | 2020 | 2560 | 0.100 |
Why?
|
| Gene Expression Profiling | 4 | 2022 | 1753 | 0.100 |
Why?
|
| Abortion, Spontaneous | 1 | 2013 | 83 | 0.100 |
Why?
|
| Tamoxifen | 1 | 2014 | 344 | 0.100 |
Why?
|
| Blood Platelets | 1 | 2015 | 312 | 0.100 |
Why?
|
| Artemisia | 1 | 2012 | 1 | 0.090 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2014 | 253 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 1705 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 744 | 0.090 |
Why?
|
| Benzo(a)pyrene | 2 | 2025 | 24 | 0.090 |
Why?
|
| Interferon-gamma | 3 | 2020 | 519 | 0.090 |
Why?
|
| Genomics | 2 | 2024 | 1545 | 0.090 |
Why?
|
| RNA, Small Interfering | 3 | 2021 | 658 | 0.090 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 39 | 0.090 |
Why?
|
| Cytochrome P-450 CYP1B1 | 1 | 2011 | 30 | 0.090 |
Why?
|
| Purine-Nucleoside Phosphorylase | 1 | 2011 | 9 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 1048 | 0.090 |
Why?
|
| Lipopolysaccharides | 2 | 2023 | 291 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 588 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 533 | 0.090 |
Why?
|
| Biomarkers | 4 | 2024 | 3219 | 0.090 |
Why?
|
| Methylation | 1 | 2011 | 196 | 0.090 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 5113 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 999 | 0.090 |
Why?
|
| Models, Biological | 2 | 2017 | 1370 | 0.080 |
Why?
|
| HEK293 Cells | 2 | 2025 | 767 | 0.080 |
Why?
|
| Phenotype | 3 | 2021 | 4302 | 0.080 |
Why?
|
| Plant Extracts | 1 | 2012 | 132 | 0.080 |
Why?
|
| Binding Sites | 2 | 2025 | 1185 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1597 | 0.080 |
Why?
|
| Germ-Free Life | 2 | 2020 | 61 | 0.080 |
Why?
|
| Adolescent | 3 | 2020 | 19987 | 0.080 |
Why?
|
| Mice, SCID | 3 | 2016 | 568 | 0.080 |
Why?
|
| Stroke | 1 | 2018 | 1025 | 0.080 |
Why?
|
| Ketoglutaric Acids | 2 | 2022 | 23 | 0.080 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2021 | 199 | 0.080 |
Why?
|
| PPAR gamma | 2 | 2020 | 86 | 0.080 |
Why?
|
| Testosterone | 1 | 2015 | 598 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2016 | 477 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2021 | 2893 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2025 | 576 | 0.070 |
Why?
|
| Transfection | 2 | 2021 | 946 | 0.070 |
Why?
|
| Pregnancy | 4 | 2025 | 7370 | 0.070 |
Why?
|
| Lipogenesis | 2 | 2021 | 62 | 0.070 |
Why?
|
| ARNTL Transcription Factors | 2 | 2021 | 44 | 0.070 |
Why?
|
| Citric Acid Cycle | 2 | 2018 | 42 | 0.070 |
Why?
|
| Epithelial Cells | 2 | 2023 | 870 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 968 | 0.070 |
Why?
|
| Primary Cell Culture | 2 | 2018 | 103 | 0.070 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2019 | 167 | 0.070 |
Why?
|
| Transcription, Genetic | 3 | 2019 | 1377 | 0.070 |
Why?
|
| RNA Interference | 2 | 2020 | 492 | 0.070 |
Why?
|
| RNA, Messenger | 3 | 2020 | 2537 | 0.070 |
Why?
|
| Lysophospholipids | 2 | 2017 | 36 | 0.070 |
Why?
|
| Nicotine | 2 | 2019 | 109 | 0.070 |
Why?
|
| Stromal Cells | 2 | 2021 | 301 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 2 | 2020 | 986 | 0.060 |
Why?
|
| HeLa Cells | 2 | 2019 | 684 | 0.060 |
Why?
|
| Uropathogenic Escherichia coli | 1 | 2026 | 24 | 0.060 |
Why?
|
| MCF-7 Cells | 2 | 2017 | 207 | 0.060 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2025 | 31 | 0.060 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2025 | 44 | 0.060 |
Why?
|
| Infant, Newborn | 3 | 2025 | 8343 | 0.060 |
Why?
|
| Lipid Peroxidation | 1 | 2025 | 90 | 0.060 |
Why?
|
| Enzyme Inhibitors | 2 | 2021 | 563 | 0.060 |
Why?
|
| Dasatinib | 1 | 2025 | 48 | 0.060 |
Why?
|
| Neoplasm Transplantation | 2 | 2016 | 361 | 0.060 |
Why?
|
| Jamaica | 1 | 2024 | 27 | 0.050 |
Why?
|
| Hexokinase | 1 | 2024 | 25 | 0.050 |
Why?
|
| Cellular Senescence | 1 | 2026 | 183 | 0.050 |
Why?
|
| Neoplasm Metastasis | 2 | 2018 | 686 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2019 | 726 | 0.050 |
Why?
|
| CD24 Antigen | 1 | 2024 | 30 | 0.050 |
Why?
|
| Escherichia coli Infections | 1 | 2026 | 184 | 0.050 |
Why?
|
| Pancreatic Stellate Cells | 1 | 2023 | 7 | 0.050 |
Why?
|
| Receptors, Purinergic | 1 | 2023 | 14 | 0.050 |
Why?
|
| Receptors, Purinergic P2Y2 | 1 | 2023 | 17 | 0.050 |
Why?
|
| Depression | 2 | 2024 | 1293 | 0.050 |
Why?
|
| Flavin-Adenine Dinucleotide | 1 | 2023 | 9 | 0.050 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2025 | 169 | 0.050 |
Why?
|
| Flavoproteins | 1 | 2023 | 20 | 0.050 |
Why?
|
| Taurine | 1 | 2023 | 11 | 0.050 |
Why?
|
| Indoles | 1 | 2024 | 199 | 0.050 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2023 | 33 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2025 | 420 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 523 | 0.050 |
Why?
|
| Cyclin D2 | 1 | 2023 | 14 | 0.050 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2023 | 125 | 0.050 |
Why?
|
| Metformin | 1 | 2025 | 159 | 0.050 |
Why?
|
| Centrosome | 1 | 2023 | 24 | 0.050 |
Why?
|
| Spindle Apparatus | 1 | 2023 | 46 | 0.050 |
Why?
|
| Acetylation | 1 | 2023 | 181 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2024 | 302 | 0.050 |
Why?
|
| Uridine Diphosphate | 1 | 2022 | 4 | 0.050 |
Why?
|
| Neoplastic Processes | 1 | 2022 | 6 | 0.050 |
Why?
|
| Age Factors | 2 | 2020 | 2788 | 0.050 |
Why?
|
| Fumarates | 1 | 2022 | 17 | 0.050 |
Why?
|
| Drosophila | 2 | 2017 | 767 | 0.050 |
Why?
|
| Citrates | 1 | 2022 | 26 | 0.050 |
Why?
|
| Dinoprostone | 1 | 2022 | 67 | 0.050 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2024 | 226 | 0.050 |
Why?
|
| Mitosis | 1 | 2023 | 190 | 0.050 |
Why?
|
| Particulate Matter | 1 | 2022 | 75 | 0.050 |
Why?
|
| NAD | 1 | 2022 | 50 | 0.050 |
Why?
|
| Fasting | 1 | 2023 | 300 | 0.050 |
Why?
|
| Hedgehog Proteins | 1 | 2023 | 197 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 1350 | 0.050 |
Why?
|
| Acetylgalactosamine | 1 | 2021 | 11 | 0.050 |
Why?
|
| Thioredoxin Reductase 1 | 1 | 2021 | 4 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2024 | 494 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2021 | 156 | 0.040 |
Why?
|
| Drosophila melanogaster | 2 | 2017 | 808 | 0.040 |
Why?
|
| Telomere-Binding Proteins | 1 | 2021 | 44 | 0.040 |
Why?
|
| Gestational Age | 1 | 2025 | 1186 | 0.040 |
Why?
|
| Arginine | 1 | 2023 | 335 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2021 | 169 | 0.040 |
Why?
|
| Heterografts | 1 | 2021 | 190 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 247 | 0.040 |
Why?
|
| Brain | 2 | 2024 | 3037 | 0.040 |
Why?
|
| Fluorocarbons | 1 | 2021 | 61 | 0.040 |
Why?
|
| Receptors, Interferon | 1 | 2020 | 20 | 0.040 |
Why?
|
| Benzamides | 1 | 2021 | 120 | 0.040 |
Why?
|
| Mutant Proteins | 1 | 2021 | 111 | 0.040 |
Why?
|
| Organelle Biogenesis | 1 | 2020 | 19 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 2020 | 109 | 0.040 |
Why?
|
| Bifidobacterium longum | 1 | 2020 | 3 | 0.040 |
Why?
|
| Clostridium symbiosum | 1 | 2020 | 3 | 0.040 |
Why?
|
| Faecalibacterium prausnitzii | 1 | 2020 | 5 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2023 | 767 | 0.040 |
Why?
|
| Adipocytes, White | 1 | 2020 | 26 | 0.040 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2020 | 6 | 0.040 |
Why?
|
| Mucin-4 | 1 | 2020 | 11 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 6663 | 0.040 |
Why?
|
| Mucin-2 | 1 | 2020 | 35 | 0.040 |
Why?
|
| Enterotoxins | 1 | 2020 | 76 | 0.040 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2020 | 36 | 0.040 |
Why?
|
| Pancreas | 1 | 2021 | 215 | 0.040 |
Why?
|
| Period Circadian Proteins | 1 | 2020 | 25 | 0.040 |
Why?
|
| Interleukin-9 | 1 | 2020 | 7 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 150 | 0.040 |
Why?
|
| Antimetabolites | 1 | 2020 | 28 | 0.040 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2020 | 38 | 0.040 |
Why?
|
| Oligopeptides | 1 | 2020 | 115 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 235 | 0.040 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2020 | 111 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 2020 | 111 | 0.040 |
Why?
|
| Chemokine CXCL10 | 1 | 2020 | 51 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2021 | 404 | 0.040 |
Why?
|
| Vitamin B 12 | 1 | 2020 | 57 | 0.040 |
Why?
|
| Overweight | 1 | 2023 | 370 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2019 | 90 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2022 | 669 | 0.040 |
Why?
|
| Uridine Diphosphate Glucuronic Acid | 1 | 2019 | 6 | 0.040 |
Why?
|
| Endocrine Disruptors | 1 | 2020 | 53 | 0.040 |
Why?
|
| Chorioallantoic Membrane | 1 | 2019 | 12 | 0.040 |
Why?
|
| Solvents | 1 | 2019 | 43 | 0.040 |
Why?
|
| Macrophages, Alveolar | 1 | 2019 | 48 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 277 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2020 | 72 | 0.040 |
Why?
|
| Adipocytes | 1 | 2020 | 167 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2019 | 130 | 0.040 |
Why?
|
| Interleukin-17 | 1 | 2020 | 124 | 0.040 |
Why?
|
| Gene-Environment Interaction | 1 | 2020 | 126 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2021 | 781 | 0.040 |
Why?
|
| Smoke | 1 | 2019 | 53 | 0.040 |
Why?
|
| Chick Embryo | 1 | 2019 | 113 | 0.040 |
Why?
|
| Leukocytes | 1 | 2020 | 202 | 0.040 |
Why?
|
| Collagen Type IV | 1 | 2019 | 19 | 0.040 |
Why?
|
| Snail Family Transcription Factors | 1 | 2019 | 25 | 0.040 |
Why?
|
| Epigenomics | 1 | 2020 | 173 | 0.040 |
Why?
|
| Respiratory Mucosa | 1 | 2019 | 96 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2021 | 646 | 0.040 |
Why?
|
| Twist-Related Protein 1 | 1 | 2019 | 34 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2021 | 244 | 0.040 |
Why?
|
| Zebrafish | 1 | 2021 | 402 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2019 | 4953 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2019 | 158 | 0.040 |
Why?
|
| Drug Monitoring | 1 | 2021 | 274 | 0.040 |
Why?
|
| Fibrosis | 1 | 2020 | 400 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2019 | 168 | 0.040 |
Why?
|
| Syndrome | 1 | 2021 | 1135 | 0.040 |
Why?
|
| Autoantigens | 1 | 2019 | 104 | 0.040 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2018 | 59 | 0.040 |
Why?
|
| Pulmonary Emphysema | 1 | 2019 | 91 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 1 | 2020 | 225 | 0.040 |
Why?
|
| Phosphoserine | 1 | 2018 | 36 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2018 | 55 | 0.040 |
Why?
|
| Succinates | 1 | 2018 | 19 | 0.040 |
Why?
|
| Transketolase | 1 | 2018 | 17 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2018 | 34 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 223 | 0.030 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 47 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2018 | 48 | 0.030 |
Why?
|
| Biological Transport | 1 | 2018 | 327 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2020 | 330 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 61 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2021 | 792 | 0.030 |
Why?
|
| Muscle Strength | 1 | 2018 | 79 | 0.030 |
Why?
|
| Anxiety | 1 | 2024 | 964 | 0.030 |
Why?
|
| Breast | 1 | 2019 | 208 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2018 | 192 | 0.030 |
Why?
|
| Lysosomes | 1 | 2019 | 248 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2017 | 85 | 0.030 |
Why?
|
| Fatty Acid Transport Proteins | 1 | 2017 | 11 | 0.030 |
Why?
|
| Butanones | 1 | 2017 | 7 | 0.030 |
Why?
|
| Apolipoprotein E2 | 1 | 2017 | 16 | 0.030 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2017 | 24 | 0.030 |
Why?
|
| Acetylcholine Release Inhibitors | 1 | 2017 | 18 | 0.030 |
Why?
|
| Purines | 1 | 2018 | 111 | 0.030 |
Why?
|
| Nitrosamines | 1 | 2017 | 15 | 0.030 |
Why?
|
| Peroxisomal Biogenesis Factor 2 | 1 | 2017 | 4 | 0.030 |
Why?
|
| Adenoma | 1 | 2019 | 143 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 3262 | 0.030 |
Why?
|
| Azacitidine | 1 | 2017 | 51 | 0.030 |
Why?
|
| Nitrogenous Group Transferases | 1 | 2017 | 4 | 0.030 |
Why?
|
| Proteomics | 2 | 2012 | 562 | 0.030 |
Why?
|
| Phosphatidylethanolamines | 1 | 2017 | 22 | 0.030 |
Why?
|
| Cysteine | 1 | 2018 | 137 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2018 | 142 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2018 | 106 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2023 | 1004 | 0.030 |
Why?
|
| Malaria, Falciparum | 1 | 2017 | 67 | 0.030 |
Why?
|
| Pericytes | 1 | 2017 | 21 | 0.030 |
Why?
|
| Histone Deacetylase 2 | 1 | 2017 | 15 | 0.030 |
Why?
|
| Histone Deacetylase 1 | 1 | 2017 | 20 | 0.030 |
Why?
|
| Diglycerides | 1 | 2017 | 16 | 0.030 |
Why?
|
| Phosphorylcholine | 1 | 2017 | 30 | 0.030 |
Why?
|
| Sphingosine | 1 | 2017 | 20 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 2017 | 96 | 0.030 |
Why?
|
| Memory | 1 | 2020 | 346 | 0.030 |
Why?
|
| WT1 Proteins | 1 | 2017 | 22 | 0.030 |
Why?
|
| Calcium | 1 | 2022 | 1031 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2022 | 490 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 2017 | 144 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2017 | 246 | 0.030 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2017 | 38 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2017 | 85 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2017 | 230 | 0.030 |
Why?
|
| Phosphatidylserines | 1 | 2017 | 46 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2017 | 70 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2017 | 229 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 291 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2018 | 381 | 0.030 |
Why?
|
| Risk Factors | 2 | 2023 | 10545 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 147 | 0.030 |
Why?
|
| ROC Curve | 1 | 2018 | 587 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2022 | 823 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2016 | 28 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2023 | 1654 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 456 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2018 | 354 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 808 | 0.030 |
Why?
|
| Time Factors | 2 | 2018 | 6126 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2017 | 154 | 0.030 |
Why?
|
| Lysine | 1 | 2016 | 173 | 0.030 |
Why?
|
| Intestines | 1 | 2020 | 578 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2016 | 169 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2017 | 228 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 416 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2017 | 408 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2018 | 379 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 222 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 277 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2018 | 269 | 0.030 |
Why?
|
| Weight Loss | 1 | 2019 | 503 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 235 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2018 | 824 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2015 | 156 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 396 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 66 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2017 | 373 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2018 | 461 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2015 | 333 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2015 | 203 | 0.030 |
Why?
|
| Hemin | 1 | 2014 | 14 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2019 | 677 | 0.030 |
Why?
|
| Artemisinins | 1 | 2014 | 12 | 0.030 |
Why?
|
| Diet | 1 | 2021 | 1100 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 538 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 330 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 192 | 0.030 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2014 | 25 | 0.030 |
Why?
|
| Algorithms | 1 | 2021 | 1633 | 0.030 |
Why?
|
| CLOCK Proteins | 1 | 2014 | 34 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2014 | 151 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 348 | 0.030 |
Why?
|
| Neurodegenerative Diseases | 1 | 2016 | 272 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 398 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2017 | 501 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2015 | 228 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 258 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 1728 | 0.020 |
Why?
|
| Decidua | 1 | 2013 | 135 | 0.020 |
Why?
|
| Neuroprotective Agents | 1 | 2014 | 155 | 0.020 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 198 | 0.020 |
Why?
|
| Computational Biology | 1 | 2017 | 834 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 63 | 0.020 |
Why?
|
| Cell Movement | 1 | 2015 | 849 | 0.020 |
Why?
|
| Embryo Implantation | 1 | 2013 | 223 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2014 | 742 | 0.020 |
Why?
|
| Texas | 1 | 2019 | 3545 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2017 | 1569 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 2969 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 1482 | 0.020 |
Why?
|
| Proteome | 1 | 2011 | 273 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2024 | 14336 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 3583 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 3693 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 2882 | 0.010 |
Why?
|
| Child | 1 | 2024 | 25081 | 0.010 |
Why?
|